Retrospective study of hepatic encephalopathy by different transjugular intrahepatic portosystemic shunt ways in portal hypertension

• Main Authors: Xin Huo, Xiao Wen Cui, Min Wang, Chong Jing, Yue Wu, Xin Ming Yu, Hui Zhou, Wen-Peng Li, Xue-Chao Cai, Guan-Zhou Zhou, Yong-Jie Zhang
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2019-01-01
• Series: Vascular Investigation and Therapy
• Subjects: hepatic encephalopathy; portal hypertension; transjugular intrahepatic portosystemic shunt
• Online Access: http://www.vitonline.org/article.asp?issn=2589-9686;year=2019;volume=2;issue=1;spage=15;epage=18;aulast=Huo

OBJECTIVE: The objective of the study was to evaluate the effectiveness and safety of the use of different shunting ways in patients with liver cirrhosis undergoing transjugular intrahepatic portosystemic shunt (TIPS). MATERIALS AND METHODS: We analyzed the data of 36 patients with liver cirrhosis who received de novo TIPS implantation. Sixteen patients had elective TIPS by shunting the blood to the left downstream veins and 20 to the right ones. All patients were followed up for 2 years. We assessed hepatic encephalopathy (HE), rebleeding, and survival rate in all patients post-TIPS. RESULTS: Under our surgical procedure, more post-TIPS HE was observed in the TIPS-left group, whereas rebleeding was detected in the TIPS-right group (P < 0.05). CONCLUSIONS: The decision regarding TIPS placement way for portal hypertension patients needs individualization to allow its safe use, with concomitant improvement in perioperative morbidity.